Preconditioning the human myocardium: Recent advances and aspirations for the development of a new means of cardioprotection in clinical practice David P. JenkinsStephen E. SteareDerek M. Yellon Reviews Pages: 739 - 747
Additional antiischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy G. Louis BartelsWillem J. RemmeDick A. C. M. Kruijssen Angina Pectoris Pages: 749 - 753
Effect of nicorandil on abnormal coronary flow reserve assessed by exercise201Tl scintigraphy in patients with angina pectoris and nearly normal coronary arteriograms Hiroshi YamabeHiroyuki NamuraMitsuhiro Yokoyama Angina Pectoris Pages: 755 - 761
Randomized, controlled trial of antioxidant vitamins and cardioprotective diet on hyperlipidemia, oxidative stress, and development of experimental atherosclerosis: The diet and antioxidant trial on atherosclerosis (DATA) Ram B. SinghArif M. NiazFred A. Kummerow Atherosclerosis Pages: 763 - 771
Iloprost antagonizes the increase in internal calcium concentration induced by α-thrombin in human platelets: A study of desensitization Enrica CecchiLaura CaponePaola Failli Platelet Function Pages: 773 - 777
“Essential” phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease Anatoli N. KlimovVladimir O. KonstantinovRainer Schumacher Lipids Pages: 779 - 784
Behavior of Lp(a) and apoproteins (A1, B, C2, C3, E) during and after therapy with simvastatin T. SampietroF. GalettaA. Bionda Lipids Pages: 785 - 789
Intravenous dopexamine in the treatment of acute congestive heart failure: Results of a multicenter, double-blind, placebo-controlled withdrawal study Hidetsugu AsanoiShigetake Sasayamathe Investigators of the Dopexamine Multicenter Study Congestive Heart Failure Pages: 791 - 797
24 hour blood pressure control with once-daily versus twice-daily formulations of diltiazem Terrence D. RuddyJames M. WrightThe Canadian Multicenter Diltiazem CD Hypertension Trial Group Hypertension Pages: 799 - 807
Semotiadil inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension Takashi TakahashiTsugiyasu KandaKazuhiko Murata Experimental Pharmacology Pages: 809 - 814
Blockade of receptor-operated calcium channels by mibefradil (Ro 40-5967): Effects on intracellular calcium and platelet aggregation Martina HahnVsevolod A. TkachukJean-Paul Clozel Experimental Pharmacology Pages: 815 - 821
Effects of Na+-H+ exchange blocker amiloride on left ventricular remodeling after anterior myocardial infarction in rats Shuuichi HasegawaMasayuki NakanoTadashi Suzuki Experimental Pharmacology Pages: 823 - 826
Sudden hypothyroidism and amiodarone-lithium combination: An interaction Saeed Ahmad Experimental Pharmacology Pages: 827 - 828
Increase of plasma digoxin levels after withdrawal from therapy in an elderly patient Zijad Duraković Letter To The Editor Pages: 829 - 830
Does plasma endothelin during thrombolysis depend on infarct size? A pilot study Pietro Di PasqualeSalvatore PaternaGiuseppe Licata Letter To The Editor Pages: 831 - 832